Skip directly to site content Skip directly to page options Skip directly to A-Z link


Centers for Disease Control and Prevention. CDC twenty four seven. Saving Lives, Protecting People
														Search
		×
			NIOSH
			NIOSH
				All CDC
				Submit
			For a full list of topics:A-Z Index
			Advanced Search
		Advanced Search


The National Institute for Occupational Safety and Health (NIOSH)


Facebook
        Twitter
        LinkedIn
        Syndicate





TANTALUM METAL								Related Pages
										*OSHA comments from the January 19, 1989 Final Rule on Air Contaminants Project extracted from 54FR2332 et. seq. This rule was remanded by the U.S. Circuit Court of Appeals and the limits are not currently in force.*
**CAS:** 7440-25-7; Chemical Formulas: Tantalum metal (Ta); Tantalum oxide (Ta2O5)
OSHA’s former PEL for tantalum is 5 mg/m3. The Agency proposed to retain this limit and to supplement it with a 15-minute STEL of 10 mg/m3, and NIOSH (Ex. 8-47, Table N1) concurred with this proposal. The final rule retains an 8-hour TWA for tantalum metal dust and oxide but does not adopt the proposed STEL for these substances (see Section XI.C.17 for a discussion of OSHA’s rationale in regard to STELs). The ACGIH has a 5-mg/m3 TWA but has recently deleted its former 15-minute STEL of 10 mg/m3. Tantalum dust is a black powder and tantalum oxide is a white, microcrystalline powder.
Animal studies by Miller, Davis, Goldman, and Wyatts (1953/Ex. 1-40) have not implicated tantalum as a cause of pnuemoconiosis, although an exposure to 100 mg tantalum oxide produced “soft white circumscribed pigmented dust lesions” in the lungs of these animals (ACGIH 1986/Ex. 1-3, p. 554). Additionally, this particular study demonstrated transient bronchitis, interstitial pneumonitis, and hyperemia at the 100-mg exposure level. Tantalum oxide has been used as a dressing for burns (Olsen 1944/Ex. 1-651), and the use of tantalum gauze in surgical repair produced no long-term adverse effects (Dales and Kyle 1958/Ex. 1-587). No adverse health effects have been associated with industrial exposures to tantalum or its compounds (Cochran, Doull, Mazur, and DuBois 1950/Ex. 1-586). A single oral dose of 6500 mg/kg oxide was virtually nontoxic to rats (ACGIH 1986/Ex. 1-3, p. 554).
OSHA concludes that the existing 5-mg/m3 TWA for these compounds should be retained to protect workers from the respiratory effects of exposure, which constitute material health impairments. The final rule retains the Agency’s former PEL of 5 mg/m3 for tantalum (metal dust and oxide).
										
							
								Page last reviewed:  September 28, 2011						Content source:  	National Institute for Occupational Safety and Health NIOSH
1988 OSHA PEL Project Documentation
Index of Chemical Names
Index of CAS Numbers Follow NIOSH Facebook
Pinterest
Twitter
YouTube
 NIOSH Homepage NIOSH A-Z
Workplace Safety & Health Topics
Publications and Products
Programs
Contact NIOSH


About CDC
					Contact Us
					800-232-4636
 Facebook Twitter Instagram LinkedIn Youtube Pinterest Snapchat
 CONTACT CDC
				Contact Us
							Call 800-232-4636
							Email Us
			ABOUT CDC
				About CDC
							Jobs
							Funding
			POLICIES
				Accessibility
							External Links
							Privacy
							Policies
							No Fear Act
							FOIA
							OIG
							Nondiscrimination
							Vulnerability Disclosure Policy
			CONNECT WITH US
				Facebook
								Twitter
								Instagram
								LinkedIn
							Youtube
								Pinterest
								Snapchat
								Email
			LANGUAGES
				Español
							繁體中文
							Tiếng Việt
							한국어
							Tagalog
							Русский
							العربية
							Kreyòl Ayisyen
							Français
							Polski
							Português
							Italiano
							Deutsch
							日本語
							فارسی
							English


U.S. Department of Health & Human Services
			Accessibility
			External Links
			Privacy
			Policies
			No Fear Act
			FOIA
			Nondiscrimination
			OIG
			Vulnerability Disclosure Policy
			USA.gov


Exit Notification / Disclaimer Policy Close
 Links with this icon  indicate that you are leaving the CDC website. The Centers for Disease Control and Prevention (CDC) cannot attest to the accuracy of a non-federal website.
				Linking to a non-federal website does not constitute an endorsement by CDC or any of its employees of the sponsors or the information and products presented on the website.
				You will be subject to the destination website's privacy policy when you follow the link.
				CDC is not responsible for Section 508 compliance (accessibility) on other federal or private website. Website Disclaimers
 Cancel Continue